Many men with prostate cancer (PCa) experience insomnia symptoms post-treatment. We explore here PCa patients' preference for strategies to manage their sleep.
A brief online survey was launched on Facebook and promoted by Prostate Cancer Foundation New Zealand.
The survey contained validated questionnaires on various sleep-related parameters, as well as questions about sleep management strategies.
We recruited 82 PCa patients (67.9 ± 6.3 years old). Participants with high insomnia severity index (ISI) scores reported significantly worse daytime sleepiness, more severe fatigue, being less of a "morning person", and more frequent dreaming. Most participants (71-95%) were open to trying behavioural strategies for improving sleep hygiene, especially by improving their sleeping conditions and having a consistent sleep-wake schedule. Insomnia severity and past use of androgen deprivation therapy were significant predictors for the number of sleep treatments used. Participants with a high ISI were more likely to have used medication, CBT, and herbal remedies or supplements for treating sleep issues than those with low ISI. Furthermore, in patients who had not used these treatments options, those with a high ISI were more willing to try CBT and hypnosis compared to those with a low ISI. Reasons for not willing to try various sleep treatments were documented.
Most PCa patients are willing to adjust their behavior or lifestyle to improve their sleep habits/behaviours. Patients with severe insomnia are more likely to have both used and express willingness to try, interventions to improve sleep, with preferences for CBT and hypnosis.
Cancer treatment and research communications. 2020 Oct 07 [Epub ahead of print]
Shenyll Delpachitra, Angela Campbell, Erik Wibowo
Department of Anatomy, University of Otago, 270 Great King St, Dunedin, New Zealand - 9016. Electronic address: ., WellSleep, Department of Medicine, University of Otago, Wellington, New Zealand. Electronic address: ., Department of Anatomy, University of Otago, 270 Great King St, Dunedin, New Zealand - 9016. Electronic address: .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/33120315